This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...

The Central and East European transition countries are pinning considerable hopes for their economic future on entry into the European Union. However, given the huge amount of catching up they still have to do in economic terms, the tough entry conditions they have to meet and the limited amount...